Results: 1-25 | 26-50 | 51-68
Results: 26-50/68

Authors: CAMPOS H WALSH BW JUDGE H SACKS FM
Citation: H. Campos et al., EFFECT OF ESTROGEN ON VERY-LOW-DENSITY LIPOPROTEIN AND LOW-DENSITY-LIPOPROTEIN SUBCLASS METABOLISM IN POSTMENOPAUSAL WOMEN, The Journal of clinical endocrinology and metabolism, 82(12), 1997, pp. 3955-3963

Authors: GOLDBERG R MOYE L HOWARD B HOWARD WH MELLIES M SACKS FM BRAUNWALD E
Citation: R. Goldberg et al., CHOLESTEROL REDUCTION WITH PRAVASTATIN IN CARE PATIENTS IS BENEFICIALIRRESPECTIVE OF FASTING GLUCOSE-LEVELS, Atherosclerosis, 134(1-2), 1997, pp. 47-47

Authors: LEWIS SJ MITCHELL JS PFEFFER MA SACKS FM BRAUNWALD E
Citation: Sj. Lewis et al., PRAVASTATIN PREVENTS STROKE IN OLDER PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 48-48

Authors: SACKS FM KHOO C JUDGE H CAMPOS H
Citation: Fm. Sacks et al., THE HUMAN LIPOPROTEIN B PARTICLE SYSTEM DEFINED BY APOLIPOPROTEIN-E AND APOLIPOPROTEIN-CIII CONTENT - METABOLIC PATHWAYS IN WOMEN AND EFFECT OF ORAL-CONTRACEPTIVES, Atherosclerosis, 134(1-2), 1997, pp. 355-355

Authors: SACKS FM MOYE LA DAVIS BR ROULEAU JL PFEFFER MA COLE TG BRAUNWALD E
Citation: Fm. Sacks et al., THE INFLUENCE ON CORONARY EVENTS OF LIPID THERAPY DURING TREATMENT WITH PRAVASTATIN - THE CARE TRIAL, Circulation, 96(8), 1997, pp. 358-358

Authors: KHOO C CAMPOS H JUDGE H SACKS FM
Citation: C. Khoo et al., THE LIPOPROTEIN-B PARTICLE SYSTEM DEFINED BY APOLIPOPROTEIN-E AND APOLIPOPROTEIN-CIII CONTENT - METABOLIC PATHWAYS IN WOMEN AND EFFECT OF ORAL-CONTRACEPTIVES, Circulation, 96(8), 1997, pp. 2311-2311

Authors: PASTERNAK RC SACKS FM
Citation: Rc. Pasternak et Fm. Sacks, HYPOLIPIDEMIC DRUGS IN CORONARY-ARTERY DISEASE - IN REPLY, Annals of internal medicine, 126(11), 1997, pp. 917-917

Authors: ASCHERIO A CHO EY WALSH K SACKS FM WILLETT WC FARUQUI A
Citation: A. Ascherio et al., PREMATURE CORONARY DEATHS IN ASIANS, BMJ. British medical journal, 312(7029), 1996, pp. 508-508

Authors: STAMPFER MJ KRAUSS RM MA J BLANCHE PJ HOLL LG SACKS FM HENNEKENS CH
Citation: Mj. Stampfer et al., A PROSPECTIVE-STUDY OF TRIGLYCERIDE LEVEL, LOW-DENSITY-LIPOPROTEIN PARTICLE DIAMETER, AND RISK OF MYOCARDIAL-INFARCTION, JAMA, the journal of the American Medical Association, 276(11), 1996, pp. 882-888

Authors: SACKS FM PFEFFER MA MOYE LA ROULEAU JL RUTHERFORD JD COLE TG BROWN L WARNICA JW ARNOLD JMO WUN CC DAVIS BR BRAUNWALD E
Citation: Fm. Sacks et al., THE EFFECT OF PRAVASTATIN ON CORONARY EVENTS AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH AVERAGE CHOLESTEROL LEVELS, The New England journal of medicine, 335(14), 1996, pp. 1001-1009

Authors: SACKS FM WUN CC COLE TG NASH DT LEPAGE S ROULEAU J MOYE LA DAVIS BR PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., THE INFLUENCE OF BASE-LINE LIPID-LEVELS ON REDUCTION IN CORONARY EVENTS BY PRAVASTATIN - THE CHOLESTEROL AND RECURRENT EVENTS TRIAL, Circulation, 94(8), 1996, pp. 3152-3152

Authors: SU WF CAMPOS H LI HJ WALSH BW SACKS FM
Citation: Wf. Su et al., THE EFFECT OF POSTMENOPAUSAL ESTROGEN-TREATMENT ON LIPOPROTEIN(A) METABOLISM, Circulation, 94(8), 1996, pp. 3416-3416

Authors: PASTERNAK RC BROWN LE STONE PH SILVERMAN DI GIBSON CM SACKS FM
Citation: Rc. Pasternak et al., EFFECT OF COMBINATION THERAPY WITH LIPID-REDUCING DRUGS IN PATIENTS WITH CORONARY HEART-DISEASE AND NORMAL CHOLESTEROL LEVELS - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 125(7), 1996, pp. 529

Authors: WILT TJ DAVIS BR MEYERS DG ROULEAU JL SACKS FM
Citation: Tj. Wilt et al., PREVALENCE AND CORRELATES OF SYMPTOMATIC PERIPHERAL ATHEROSCLEROSIS IN INDIVIDUALS WITH CORONARY HEART-DISEASE AND CHOLESTEROL LEVELS LESS-THAN 240MG DL - BASE-LINE RESULTS FROM THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY/, Angiology, 47(6), 1996, pp. 533-541

Authors: SILVA ERDO SEIDMAN CE TIAN JJ HUDGINS LC SACKS FM BRESLOW JL
Citation: Erdo. Silva et al., EFFECTS OF SHRIMP CONSUMPTION ON PLASMA-LIPOPROTEINS, The American journal of clinical nutrition, 64(5), 1996, pp. 712-717

Authors: OHANESIAN MA ROSNER B BISHOP LM SACKS FM
Citation: Ma. Ohanesian et al., EFFECTS OF INHERENT RESPONSIVENESS TO DIET AND DAY-TO-DAY DIET VARIATION ON PLASMA-LIPOPROTEIN CONCENTRATIONS, The American journal of clinical nutrition, 64(1), 1996, pp. 53-59

Authors: SACKS FM STONE PH GIBSON CM SILVERMAN DI ROSNER B PASTERNAK RC
Citation: Fm. Sacks et al., CONTROLLED TRIAL OF FISH-OIL FOR REGRESSION OF HUMAN CORONARY ATHEROSCLEROSIS, Journal of the American College of Cardiology, 25(7), 1995, pp. 1492-1498

Authors: GUALLAR E HENNEKENS CH SACKS FM WILLETT WC STAMPFER MJ
Citation: E. Guallar et al., A PROSPECTIVE-STUDY OF PLASMA FISH-OIL LEVELS AND INCIDENCE OF MYOCARDIAL-INFARCTION IN US MALE PHYSICIANS, Journal of the American College of Cardiology, 25(2), 1995, pp. 387-394

Authors: SACKS FM BROWN LE APPEL L BORHANI NO EVANS D WHELTON P
Citation: Fm. Sacks et al., COMBINATIONS OF POTASSIUM, CALCIUM, AND MAGNESIUM SUPPLEMENTS IN HYPERTENSION, Hypertension, 26(6), 1995, pp. 950-956

Authors: SACKS FM CAMPOS H WALSH BW YANG XY LI H
Citation: Fm. Sacks et al., POSTPRANDIAL METABOLISM OF HUMAN PLASMA-LIPOPROTEINS OF INTESTINAL AND HEPATIC ORIGIN DETERMINED BY ENDOGENOUS LABELING, Circulation, 92(8), 1995, pp. 744-744

Authors: CAMARGO CA HENNEKENS CH SACKS FM MA J STAMPFER MJ
Citation: Ca. Camargo et al., PROSPECTIVE-STUDY OF PLASMA-LIPOPROTEINS AND RISK OF ANGINA-PECTORIS, Circulation, 91(3), 1995, pp. 924-924

Authors: SACKS FM PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., A SYMPOSIUM - CHOLESTEROL-LOWERING TRIALS - NEW RESULTS AND EMERGING ISSUES - INTRODUCTION, The American journal of cardiology, 76(9), 1995, pp. 1-4

Authors: SACKS FM GIBSON CM ROSNER B PASTERNAK RC STONE PH
Citation: Fm. Sacks et al., THE INFLUENCE OF PRETREATMENT LOW-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATIONS ON THE EFFECT OF HYPOCHOLESTEROLEMIC THERAPY ON CORONARY ATHEROSCLEROSIS IN ANGIOGRAPHIC TRIALS, The American journal of cardiology, 76(9), 1995, pp. 78-85

Authors: PFEFFER MA SACKS FM MOYE LA BROWN L ROULEAU JL HARTLEY LH ROULEAU J GRIMM R SESTIER F WICKEMEYER W COLE TG BRAUNWALD E
Citation: Ma. Pfeffer et al., CHOLESTEROL AND RECURRENT EVENTS - A SECONDARY PREVENTION TRIAL FOR NORMOLIPIDEMIC PATIENTS, The American journal of cardiology, 76(9), 1995, pp. 98-106

Authors: FURBERG C BYINGTON RP BAKER JL COBBE SM DAVIS B FORD I GLASZIOU P HAWKINS CM KEECH AC MACMAHON S MOYE L PACKARD C PFEFFER MA SACKS FM SHEPHERD J SIMES J TONKIN A MELLIES M MCGOVERN M NICHOLAS S ANDERSON S PARK JS BARNHART M FORTUNATO J
Citation: C. Furberg et al., DESIGN, RATIONALE, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT - A COMBINED ANALYSIS OF 3 LARGE-SCALE RANDOMIZED TRIALS - LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC-DISEASE (LIPID), CHOLESTEROL AND RECURRENT EVENTS (CARE), AND WESTOF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS), The American journal of cardiology, 76(12), 1995, pp. 899-905
Risultati: 1-25 | 26-50 | 51-68